- Large metastatic involvement of pericardium, myocardium and andocardium of both heart ventricles in pulmonary adenocarcinoma2011 | First Faculty of Medicine
- Five years lasting of biological targeted therapy in pulmonary adenocarcinoma patient2013 | Publication without faculty affiliation
- Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M2007 | Central Library of Charles University
- Acquired resistance of pulmonary adenocarcinoma to initially successful targeted therapy due to EGFR mutation T790M2007 | Faculty of Medicine in Pilsen
- Crizotinib - Still "gold standard" for patients with pulmonary adenocarcinoma with ALK translocation?2017 | Faculty of Medicine in Pilsen
- Influence of expression of selected genes encoding proteins and microRNA on the risk of stage 1 pulmonary adenocarcinoma relapse2017 | Faculty of Medicine in Pilsen
- Aggressive pulmonary adenocarcinoma with new FGFR translocation and cMET mutation not responsive to crizotinib and nintedanib treatment: a case report2020 | Faculty of Medicine in Pilsen
- Chemotherapy effectivity prediction of dynamics PET/dual scans and ctDNA tumour levels in advanced pulmonary adenocarcinomasPublication without faculty affiliation
- Metastatic intracranial spread of adenocarcinoma mimicking Creutzfeldt-Jakob disease in two cases2021 | First Faculty of Medicine, Third Faculty of Medicine
- Pulmonary Adenocarcinomas of the Fetal Lung Type. A Clinicopathologic Study Indicating Differences in Histology, Epidemiology and Natural History of Low-Grade and High-Grade Forms1998 | Faculty of Medicine in Hradec Králové
- The Use of CT Pattern in Differentiating Non-invasive, Minimally Invasive and Invasive Variants of Lung Adenocarcinoma2021 | Faculty of Medicine in Pilsen
- A case report of our second NSCLC patient treated by crizotinib2013 | Faculty of Medicine in Pilsen
- When not even four ALK inhibitors are enough2020 | Faculty of Medicine in Pilsen
- Current review of immunotherapy and anti-angiogenic lung cancer treatment2019 | Faculty of Medicine in Pilsen
- Can Previous Chemotherapy Affect the Outcome of Nivolumab Treatment in Non-small Cell Lung Cancer?2022 | Central Library of Charles University, Faculty of Medicine in Pilsen, Faculty of Medicine in Hradec Králové
- Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression2016 | Central Library of Charles University
- Value of thyroid transcription factor-1 and surfactant apoprotein A in the differential diagnosis of pulmonary carcinomas: a study of 109 cases2002 | Second Faculty of Medicine
- Simultaneous cardiac and thoracic operation2006 | Second Faculty of Medicine